First Time Loading...

InfuSystem Holdings Inc
NYSE-MKT:INFU

Watchlist Manager
InfuSystem Holdings Inc Logo
InfuSystem Holdings Inc
NYSE-MKT:INFU
Watchlist
Price: 6.83 USD -0.87% Market Closed
Updated: May 15, 2024

Intrinsic Value

InfuSystem Holdings, Inc. engages in the provision of healthcare services. [ Read More ]

The intrinsic value of one INFU stock under the Base Case scenario is 10.88 USD. Compared to the current market price of 6.83 USD, InfuSystem Holdings Inc is Undervalued by 37%.

Key Points:
INFU Intrinsic Value
Base Case
10.88 USD
Undervaluation 37%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
InfuSystem Holdings Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling INFU stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
InfuSystem Holdings Inc

Provide an overview of the primary business activities
of InfuSystem Holdings Inc.

What unique competitive advantages
does InfuSystem Holdings Inc hold over its rivals?

What risks and challenges
does InfuSystem Holdings Inc face in the near future?

Has there been any significant insider trading activity
in InfuSystem Holdings Inc recently?

Summarize the latest earnings call
of InfuSystem Holdings Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for InfuSystem Holdings Inc.

Provide P/S
for InfuSystem Holdings Inc.

Provide P/E
for InfuSystem Holdings Inc.

Provide P/OCF
for InfuSystem Holdings Inc.

Provide P/FCFE
for InfuSystem Holdings Inc.

Provide P/B
for InfuSystem Holdings Inc.

Provide EV/S
for InfuSystem Holdings Inc.

Provide EV/GP
for InfuSystem Holdings Inc.

Provide EV/EBITDA
for InfuSystem Holdings Inc.

Provide EV/EBIT
for InfuSystem Holdings Inc.

Provide EV/OCF
for InfuSystem Holdings Inc.

Provide EV/FCFF
for InfuSystem Holdings Inc.

Provide EV/IC
for InfuSystem Holdings Inc.

Show me price targets
for InfuSystem Holdings Inc made by professional analysts.

What are the Revenue projections
for InfuSystem Holdings Inc?

How accurate were the past Revenue estimates
for InfuSystem Holdings Inc?

What are the Net Income projections
for InfuSystem Holdings Inc?

How accurate were the past Net Income estimates
for InfuSystem Holdings Inc?

What are the EPS projections
for InfuSystem Holdings Inc?

How accurate were the past EPS estimates
for InfuSystem Holdings Inc?

What are the EBIT projections
for InfuSystem Holdings Inc?

How accurate were the past EBIT estimates
for InfuSystem Holdings Inc?

Compare the revenue forecasts
for InfuSystem Holdings Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of InfuSystem Holdings Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of InfuSystem Holdings Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of InfuSystem Holdings Inc compared to its peers.

Compare the P/E ratios
of InfuSystem Holdings Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing InfuSystem Holdings Inc with its peers.

Analyze the financial leverage
of InfuSystem Holdings Inc compared to its main competitors.

Show all profitability ratios
for InfuSystem Holdings Inc.

Provide ROE
for InfuSystem Holdings Inc.

Provide ROA
for InfuSystem Holdings Inc.

Provide ROIC
for InfuSystem Holdings Inc.

Provide ROCE
for InfuSystem Holdings Inc.

Provide Gross Margin
for InfuSystem Holdings Inc.

Provide Operating Margin
for InfuSystem Holdings Inc.

Provide Net Margin
for InfuSystem Holdings Inc.

Provide FCF Margin
for InfuSystem Holdings Inc.

Show all solvency ratios
for InfuSystem Holdings Inc.

Provide D/E Ratio
for InfuSystem Holdings Inc.

Provide D/A Ratio
for InfuSystem Holdings Inc.

Provide Interest Coverage Ratio
for InfuSystem Holdings Inc.

Provide Altman Z-Score Ratio
for InfuSystem Holdings Inc.

Provide Quick Ratio
for InfuSystem Holdings Inc.

Provide Current Ratio
for InfuSystem Holdings Inc.

Provide Cash Ratio
for InfuSystem Holdings Inc.

What is the historical Revenue growth
over the last 5 years for InfuSystem Holdings Inc?

What is the historical Net Income growth
over the last 5 years for InfuSystem Holdings Inc?

What is the current Free Cash Flow
of InfuSystem Holdings Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for InfuSystem Holdings Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
InfuSystem Holdings Inc

Current Assets 32.5m
Cash & Short-Term Investments 822k
Receivables 20.5m
Other Current Assets 11.1m
Non-Current Assets 72.4m
PP&E 48.9m
Intangibles 10.9m
Other Non-Current Assets 12.5m
Current Liabilities 17.3m
Accounts Payable 9.8m
Other Current Liabilities 7.5m
Non-Current Liabilities 35.3m
Long-Term Debt 29.9m
Other Non-Current Liabilities 5.3m
Efficiency

Earnings Waterfall
InfuSystem Holdings Inc

Revenue
127.4m USD
Cost of Revenue
-63.4m USD
Gross Profit
64m USD
Operating Expenses
-60.7m USD
Operating Income
3.4m USD
Other Expenses
-3.3m USD
Net Income
84k USD

Free Cash Flow Analysis
InfuSystem Holdings Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

INFU Profitability Score
Profitability Due Diligence

InfuSystem Holdings Inc's profitability score is 48/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive 3-Years Revenue Growth
Positive Revenue Growth Forecast
Positive 1-Year Revenue Growth
48/100
Profitability
Score

InfuSystem Holdings Inc's profitability score is 48/100. The higher the profitability score, the more profitable the company is.

INFU Solvency Score
Solvency Due Diligence

InfuSystem Holdings Inc's solvency score is 51/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Average Altman Z-Score
51/100
Solvency
Score

InfuSystem Holdings Inc's solvency score is 51/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

INFU Price Targets Summary
InfuSystem Holdings Inc

Wall Street analysts forecast INFU stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for INFU is 15.13 USD with a low forecast of 12.63 USD and a high forecast of 17.85 USD.

Lowest
Price Target
12.63 USD
85% Upside
Average
Price Target
15.13 USD
122% Upside
Highest
Price Target
17.85 USD
161% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

INFU Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

INFU Price
InfuSystem Holdings Inc

1M 1M
-14%
6M 6M
-24%
1Y 1Y
-25%
3Y 3Y
-64%
5Y 5Y
+45%
10Y 10Y
+141%
Annual Price Range
6.83
52w Low
6.83
52w High
11.25
Price Metrics
Average Annual Return 35.88%
Standard Deviation of Annual Returns 77.86%
Max Drawdown -72%
Shares Statistics
Market Capitalization 145.4m USD
Shares Outstanding 21 264 700
Percentage of Shares Shorted 0.93%

INFU Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

InfuSystem Holdings Inc Logo
InfuSystem Holdings Inc

Country

United States of America

Industry

Health Care

Market Cap

145.4m USD

Dividend Yield

0%

Description

InfuSystem Holdings, Inc. engages in the provision of healthcare services. The company is headquartered in Rochester Hills, Michigan and currently employs 420 full-time employees. The company went IPO on 2006-06-15. The Company’s segments include Integrated Therapy Services (ITS) and Durable Medical Equipment Services (DME Services). The Company’s core service within its ITS segment is its Oncology Business. The ITS segment supplies electronic ambulatory infusion pumps and associated disposable supply kits to private oncology clinics, infusion clinics and hospital outpatient oncology clinics to be utilized in the treatment of a variety of cancers, including colorectal cancer and other disease states. Its DME Services segments core service is to sell or rent new and pre-owned pole-mounted and ambulatory infusion pumps and other Durable Medical Equipment; sell treatment-related consumables; and provide biomedical recertification, maintenance and repair services for oncology practices as well as other healthcare site settings.

Contact

MICHIGAN
Rochester Hills
3851 West Hamlin Road
+12482911210
https://ir.infusystem.com/

IPO

2006-06-15

Employees

420

Officers

CEO & Director
Mr. Richard A. DiIorio
President, COO & Director
Ms. Carrie A. Lachance B.S.N., M.B.A., R.N.
Executive VP & CFO
Mr. Barry G. Steele
Executive VP & Chief Information Officer
Mr. Addam Chupa
Executive VP & Chief HR Officer
Mr. Jerod Funke
Corporate Secretary
Jeanie Latz

See Also

Discover More
What is the Intrinsic Value of one INFU stock?

The intrinsic value of one INFU stock under the Base Case scenario is 10.88 USD.

Is INFU stock undervalued or overvalued?

Compared to the current market price of 6.83 USD, InfuSystem Holdings Inc is Undervalued by 37%.